Medical Properties Trust profit margin MPT
Gross, operating and net profit as a share of revenue over the last twelve months, from 2010.
- Net margin, 12 months
- −3.0%
- Peer median
- 9.4%
Over the twelve months to Jun 30, 2026, Medical Properties Trust kept −3.0% of its revenue as net profit.
Five years earlier its net margin was 36.9%.
The median for 10 specialty REITs of a similar size is 9.4%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin |
|---|---|
| FY2025 | −28.5% |
| FY2024 | n/a |
| FY2023 | n/a |
| FY2022 | 58.5% |
| FY2021 | 42.5% |
| FY2020 | 34.5% |
| FY2019 | 43.9% |
| FY2018 | n/a |
| FY2017 | 41.1% |
| FY2016 | 41.6% |
| FY2015 | 31.6% |
| FY2014 | 16.2% |
| FY2013 | 40.0% |
| FY2012 | 45.4% |
| FY2011 | 19.6% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year |
|---|---|---|---|
| Q2 FY26 | −3.0% | n/a | |
| Q1 FY26 | −12.6% | n/a | |
| Q4 FY25 | −28.5% | n/a | |
| Q3 FY25 | −75.8% | n/a | |
| Q2 FY25 | n/a | n/a | |
| Q1 FY25 | n/a | n/a | |
| Q4 FY24 | n/a | n/a | |
| Q3 FY24 | n/a | n/a | |
| Q2 FY24 | n/a | n/a | |
| Q1 FY24 | n/a | n/a | |
| Q4 FY23 | n/a | n/a | |
| Q3 FY23 | −2.4% | −81.9 pts |
Against its peers
Companies in REIT - Specialty nearest Medical Properties Trust's size, closest first, today.
| Company | Profit margin |
|---|---|
| MPTMedical Properties Trust | −3.0% |
| CBLCBL & Associates Properties | 37.0% |
| BXMTBlackstone Mortgage Trust | n/m |
| UMHUMH Properties | 11.5% |
| SMASmartStop Self Storage REIT | 9.4% |
| AATAmerican Assets Trust | 5.4% |
| ALXAlexanders | 79.1% |
| NTSTNETSTREIT | 9.2% |
| IVTInvenTrust Properties | 4.8% |
| LTCLTC Properties | 38.9% |
| DEAEasterly Government Properties | 2.9% |
| Peer median | 9.4% |
Where Medical Properties Trust ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Medical Properties Trust
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.